In conclusion, this study suggested that VPS9D1-AS1 acts as a vital part in facilitating ESCC progression and can be a potential biomarker for the diagnosis of patients with ESCC. The gene discussed is VPS9D1; the disease is esophageal squamous cell carcinoma.